We are live on ! Find out more
EC

EntryPoint Capital Portfolio holdings

AUM $341M
1-Year Est. Return 20.57%
This Fund
S&P 500
This Quarter Est. Return
+2.17%
1 Year Est. Return
+20.57%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$256M
AUM Growth
-$1.88M
Cap. Flow
-$2.41M
Cap. Flow %
-0.94%
Top 10 Hldgs %
4.77%
Holding
889
New
246
Increased
123
Reduced
122
Closed
250

Top Buys

Rank Stock Value
1
VICI icon
VICI Properties
VICI
+$1.25M
2
FMC icon
FMC
FMC
+$1.21M
3
CDNS icon
Cadence Design Systems
CDNS
+$1.13M
4
IPGP icon
IPG Photonics
IPGP
+$1.12M
5
NWSA icon
News Corp Class A
NWSA
+$1.11M

Sector Composition

Rank Sector Weight
1 Financials 19.81%
2 Industrials 14.79%
3 Technology 12.97%
4 Healthcare 12.24%
5 Consumer Discretionary 9.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACEL icon
601
Accel Entertainment
ACEL
$979M
$118K 0.05%
+10,379
New +$109K
CRGY icon
602
Crescent Energy
CRGY
$3.72B
$118K 0.05%
14,075
-56,433
-80% -$495K
OPTU
603
Optimum Communications Inc
OPTU
$316M
$114K 0.04%
+69,037
New +$141K
VSTS icon
604
Vestis
VSTS
$2.06B
$113K 0.04%
+16,981
New +$99K
BDN
605
Brandywine Realty Trust
BDN
$551M
$113K 0.04%
38,598
OGN icon
606
Organon & Co
OGN
$3.55B
$109K 0.04%
15,231
+3,310
+28% +$26.2K
NNDM
607
Nano Dimension
NNDM
$309M
$106K 0.04%
68,863
AREC icon
608
American Resources Corp
AREC
$186M
$103K 0.04%
+41,516
New +$138K
ESRT icon
609
Empire State Realty Trust
ESRT
$976M
$101K 0.04%
15,425
-24,743
-62% -$177K
BCRX icon
610
BioCryst Pharmaceuticals
BCRX
$2.37B
$99K 0.04%
12,691
-29,623
-70% -$214K
KYTX icon
611
Kyverna Therapeutics
KYTX
$450M
$94.5K 0.04%
+10,048
New +$74.6K
ESPR
612
DELISTED
Esperion Therapeutics
ESPR
$87K 0.03%
+23,500
New +$75.9K
VERI icon
613
Veritone
VERI
$96.7M
$83.9K 0.03%
+18,041
New +$97K
APPS icon
614
Digital Turbine
APPS
$1.02B
$83.9K 0.03%
16,778
+5,261
+46% +$29.8K
CURI icon
615
CuriosityStream
CURI
$139M
$83.1K 0.03%
21,878
-9,868
-31% -$44K
DENN
616
DELISTED
Denny's
DENN
$82.6K 0.03%
+13,281
New +$75.3K
BLND icon
617
Blend Labs
BLND
$409M
$80.4K 0.03%
26,436
GROY icon
618
Gold Royalty Corp
GROY
$593M
$80.1K 0.03%
19,817
-16,953
-46% -$64.9K
VTEX icon
619
VTEX
VTEX
$665M
$79.9K 0.03%
21,257
-5,431
-20% -$22.3K
GRAB icon
620
Grab
GRAB
$13.5B
$78.8K 0.03%
15,795
REAX icon
621
Real Brokerage
REAX
$368M
$72.7K 0.03%
19,911
CMPX icon
622
Compass Therapeutics
CMPX
$373M
$70.7K 0.03%
+13,163
New +$60.8K
NB
623
NioCorp Developments
NB
$603M
$69.1K 0.03%
+13,032
New +$89.7K
BORR
624
Borr Drilling
BORR
$1.31B
$68K 0.03%
16,862
-10,002
-37% -$33.2K
TOI icon
625
The Oncology Institute
TOI
$498M
$65.7K 0.03%
+18,456
New +$68.5K

Similar funds

EntryPoint Capital's Q4 2025 Portfolio in Review

As of Q4 2025, EntryPoint Capital held 889 positions worth $256M, down 0.73% from $258M the previous quarter. Its ten largest holdings account for 4.8% of the portfolio.

EntryPoint Capital's Q4 2025 filing shows 246 new, 123 increased, 122 reduced and 250 closed positions. Its largest new stake was VICI Properties: 41,988 shares worth $1.18M. The largest sale was Hillman Solutions, an estimated $1.1M.

By sector, the portfolio is most concentrated in Financials at 20% of assets, up from 20% a quarter earlier, followed by Industrials and Technology.

  • EntryPoint Capital's largest Q4 2025 buy was VICI Properties: 41,988 shares worth $1.18M.
  • EntryPoint Capital added most to Ameriprise Financial in Q4 2025, an estimated $877K increase.
  • EntryPoint Capital's biggest Q4 2025 reduction was Hillman Solutions, cutting an estimated $1.1M.
  • EntryPoint Capital fully exited Southern Company in Q4 2025, selling an estimated $1.03M.
  • EntryPoint Capital's ten largest holdings make up 4.8% of its $256M portfolio in Q4 2025.
  • EntryPoint Capital opened 246 new positions and closed 250 in Q4 2025.
  • EntryPoint Capital's portfolio value fell 0.73% quarter-over-quarter to $256M.

Based on EntryPoint Capital's 13F filing for Q4 2025, filed 12 Feb 2026.